Astellas Venture Management
astellasventure.com Direct investor
Astellas Venture Management is the wholly-owned venture capital organization of Astellas Pharma, investing in early-stage biotechnology companies developing therapeutic programs and platform technologies. It focuses on preclinical stage companies that align with Astellas' R&D strategy and address unmet medical needs.
Astellas Venture Management is a corporate venture arm headquartered in South San Francisco, United States. It invests directly in companies, from pre-seed to Series A, in biotechnology, therapeutics, platform technologies and drug discovery. 24 portfolio companies, as it reports.
“We will make an investment in privately owned early-stage biotechnology company focused on therapeutics programs and platform technologies for drug discovery and development.”
— Astellas Venture Management, own website
- Layer
- Direct investor
- Headquarters
- South San Francisco, United States
- Invests in
- US, UK, Japan
- Sectors
- biotechnology, therapeutics, platform technologies, drug discovery, drug development
- Portfolio
- 24 companies
Team, as Astellas Venture Management publishes it
- Satoshi Konagai Investment Lead
- Tadayoshi Hirata Investment Lead
- Shinichi Miyake Investment Lead
- Hiroyuki Usuda Investment Lead
- Amy Skarr President
- Matt Vogt Board of Managers
- Veronika Hughes-Bednar Board of Managers
Names and roles exactly as listed on astellasventure.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 36 co-investors found.
- Longwood Fund 5 shared companies: sidewinderbio.com, dembiopharma.com, solutherapeutics.com, bicycletherapeutics.com…
- Sofinnova 3 shared companies: catamaranbio.com, crescendobiologics.com, f2g.com
- Ahren Innovation Capital LLP 2 shared companies: mogrify.co.uk, bicycletherapeutics.com
- Lightstone Ventures 2 shared companies: tizonatx.com, trishulatx.com
- Andera Partners 1 shared company: crescendobiologics.com
- IP Group plc 1 shared company: crescendobiologics.com
- Quan Capital Management, LLC 1 shared company: crescendobiologics.com
- Advent Life Sciences LLP 1 shared company: f2g.com
- Aisling Capital Management LP 1 shared company: f2g.com
- AMR Action Fund 1 shared company: f2g.com
and 26 more — the graph.
Where this comes from
Every fact above was read from a page Astellas Venture Management publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.astellasventure.com/name, is_investor, layer, type, hq_country, hq_city, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, status
- https://www.astellasventure.com/home/portfolioinvests_in_geographies, portfolio_count
- https://www.astellasventure.com/home/teampeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 1203 · added 2026-08-28 · link last verified 2026-09-06 · confidence high
Similar investors
- DanaherCorporate venture · Washington, United States
- LG Technology VenturesCorporate venture · Seed – Growth · Silicon Valley, United States
- Accenture VenturesCorporate venture · United States
- Airbus VenturesCorporate venture · Menlo Park, United States
- Alexa FundCorporate venture · United States
- BMW i VenturesCorporate venture · Seed – Series B · Mountain View, United States